Table 1.

Planned study cohorts.

ASD Cohort	TD Cohort
Approximately 150 individuals with ASD aged ≥6 years No requirements or restrictions regarding concurrent therapies or treatments	Approximately 30 normally developing individuals with ASD aged ≥6 years, with ~5 individuals in each subgroup of ages 6–9 years, 10–12 years, 13–17 years, and ≥18 years
A 14-day screening phase, and an 8–10-week data collection phase extending from Day 0 (Baseline) to endpoint was planned	Single visit and single session with JAKE Task Battery and JAKE Sense
Optional: After the endpoint visit, participants may continue to use My JAKE and the Microsoft® HealthVault pHR to contribute data to the study until the end of the study

ASD, autism spectrum disorder; JAKE, Janssen Autism Knowledge Engine; pHR, personal healthcare record.